Clinical Research Directory

Inclusion Criteria: 1. Male patients aged 18 years or older. 2. Patients with clinically diagnosed, pathologically diagnosed, or clinically suspected prostate cancer. 3. Patients who underwent PSMA PET/CT for initial staging, recurrence assessment, treatment response evaluation, metastatic assessment, or other clinical purposes during routine care. 4. Complete or basically complete Chinese PSMA PET/CT report text is available, including imaging findings and/or diagnostic impression. 5. The report text contains information that can be used to evaluate at least one target field, such as local prostate lesion, regional lymph nodes, non-regional lymph nodes, bone metastasis, visceral metastasis, or uncertainty expressions. 6. The research data can be de-identified and replaced by a study identification number before analysis. Exclusion Criteria: 1. PSMA PET/CT reports unrelated to prostate cancer, or reports clearly irrelevant to the research task. 2. Reports with severely missing, unreadable, or unavailable main text, imaging findings, or diagnostic impression. 3. Reports that cannot be adequately de-identified or contain residual direct personal identifiers that cannot be safely removed. 4. Duplicate records, repeated exports of the same examination, or records for which the unique report version cannot be confirmed. 5. Reports judged by the research team to be of insufficient quality for manual annotation, model evaluation, or statistical analysis.